Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.420
-0.030 (-2.07%)
At close: Jun 8, 2026, 4:00 PM EDT
1.440
+0.020 (1.41%)
After-hours: Jun 8, 2026, 7:53 PM EDT
Coherus Oncology Market Cap
Coherus Oncology has a market cap or net worth of $219.03 million as of June 8, 2026. Its market cap has increased by 144.46% in one year.
Market Cap
219.03M
Enterprise Value
106.36M
1-Year Change
144.46%
Ranking
Category
Stock Price
$1.42
Market Cap Chart
Since November 6, 2014, Coherus Oncology's market cap has decreased from $404.20M to $219.03M, a decrease of -45.81%. That is a compound annual growth rate of -5.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 223.70M | 30.36% |
| Dec 31, 2025 | 171.60M | 7.92% |
| Dec 31, 2024 | 159.00M | -57.12% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
| Nov 6, 2014 | 404.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orchestra BioMed Holdings | 233.53M |
| Codexis | 232.70M |
| Minerva Neurosciences | 231.08M |
| Fate Therapeutics | 230.79M |
| Entrada Therapeutics | 229.53M |
| AC Immune | 223.20M |
| Q32 Bio | 222.30M |
| Cellectis | 221.33M |